| Catalog Number |
8065751795 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Conjunctivitis (1784); Endophthalmitis (1835); Uveitis (2122); Blurred Vision (2137); Toxic Anterior Segment Syndrome (TASS) (4469); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
|
| Date of Event |
12/17/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
|
| |
|
Event or Problem Description
|
|
A physician reported that after cataract surgery by using an irrigation/aspiration (i/a) handpiece and phacoemulsification handpiece, a patient experienced severe endophthalmitis or toxic anterior segment syndrome (tass).Additional related information was requested but has not been provided to date.
|
| |
|
Additional Manufacturer Narrative
|
|
The manufacturer internal reference number is: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
The manufacturer internal reference number is: (b)(4).
|
| |
|
Event or Problem Description
|
|
Additional information received indicating that a patient underwent cataract surgery with iol implantation in left eye.After 3 days of surgery the patient experienced with strong inflammation with suspicion of endophthalmitis or tass, conjunctival inflammation: 2+, cells in the anterior chamber: 3+, fibrin in the anterior chamber.Patient was treated with subconjunctival injection: glucocorticoid, other: reinforcement local corticosteroid treatment: antibiotic + corticosteroids 6 times a days; corticosteroid + antibiotic 3 times a days; fluoroquinolones + antibiotics 6 times a days.Medication was effective and patient symptoms were resolved.
|
| |
|
Additional Manufacturer Narrative
|
|
The manufacturer internal reference number is: (b)(4).
|
| |
|
Event or Problem Description
|
|
New information received indicating viscoelastic, balanced salt solution and procedure pak is also a suspect for the adverse event.
|
| |
|
Search Alerts/Recalls
|